Enterocutaneous Fistulas Clinical Trial
Verified date | November 2013 |
Source | Jinling Hospital, China |
Contact | n/a |
Is FDA regulated | No |
Health authority | China: Food and Drug Administration |
Study type | Observational |
For non-healing ulcers, abnormal periods of wound healing processes: inflammation, proliferation and remodelling, are believed to lead to chronic wounds. As a chronic "stalled" wound, investigators hypothesized that these glue-assisted closure (GAC)-failed enterocutaneous fistula (ECF) might have a prolonged inflammatory phase modulated by excessive pro-inflammatory cytokines or proteases. The aim of this study was to analyze the chemicals in ECF wounds in order to determine patients' condition and fitness for GAC.
Status | Completed |
Enrollment | 22 |
Est. completion date | March 2013 |
Est. primary completion date | March 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - above 18 years old; - single tubular (tract length >2 cm) ECF; - low output volume (<200 ml/24h); Exclusion Criteria: - fistulas of cancer-infiltrated; - associated abscess; - foreign bodies; - distal bowel obstruction; |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Jianan Ren |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Fistula closure after glue application | No fistula output | 7 days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01561066 -
Autologous Fibrin Glues for Fistulas Closure
|
Phase 1 | |
Recruiting |
NCT06009744 -
Vitamin C and Zinc in Patients With Enterocutaneous Fistulas.
|
N/A |